Professional Physical Therapy is a leading provider of outpatient physical therapy and rehabilitation services throughout New York, New…
Author: admin
Immuno-oncology Cell Therapy Market worth $34.69 Billion by 2030 – Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on “Global Immuno-Oncology Cell Therapy…
Cardiovascular Proximal Anastomosis Devices Market to Reach US$ 23.6 Mn by 2030, Says TMR Report
In recent times, the use of robotics has risen in cardiac surgeries and the minimally invasive…
Blood-Grouping Reagents Market to Grow by USD 485.33 million | Increasing Prevalence of Chronic Disorders to Drive Growth | Technavio
The “Blood-Grouping Reagents Market by End-user (hospitals and blood banks, clinical laboratories, and academic and research…
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Highlights
Randomized phase 2 metastatic breast cancer trial (BRACELET-1) on track for top-line data in Q4 2022…
Potrero Medical, a Predictive Health Company, Selected As A Featured Innovator at LSI 2022 Medtech Investor Summit
Potrero Medical, a predictive health company and innovator of the Accuryn Monitoring System, is returning as a…
Ophthalmologists Welcome Genentech’s Vabysmo, Though Overthrowing Regeneron’s Eylea Will Be No Small Feat, Spherix Reports
Spherix Global Insights, an independent market intelligence firm, recently collected feedback from 103 US ophthalmologists on the neovascular…
Dale Medical Products, Inc. Becomes a 100% Employee-Owned Company
– Dale Medical Products, Inc. (“Dale”), a well-known manufacturer of medical devices, is pleased to announce it…
Covenant Health and Medline Partner to Enhance Supply Chain Strategy and Outcomes
Medline today announced a $75 million prime vendor partnership with Massachusetts-based Covenant Health. The two organizations will collaborate to identify new…
Blueprint Medicines Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and…